OBJECTIVES: To ascertain childhood tuberculosis (TB) trends, human immunodeficiency virus (HIV) co-infection rates and multi-drug resistant TB (MDR-TB) prevalence rates in Zambia. METHODS: A retrospective review of Zambian annual TB notification data and National TB Programme reports for a 7 year period (2004-2011). TB trends were stratified by age and HIV status. RESULTS: The total number of children notified during this period with all forms of TB was 40 976. A total of 2670 of 40 976 (6%) were smear-positive cases. Notification rates of all forms of childhood TB show a decline in trends from 135 per 100 000 population in 2004, to 69 per 100 000 population in 2011. CONCLUSIONS: Childhood TB is an important but neglected problem in Zambia highlighted by the fact that no data exists on HIV co-infection and MDR-TB. Strengthening of the National TB Programme and diagnostics services/algorithms are required to accurately define the TB burden, HIV co-infection and MDR-TB rates in children in Zambia.
OBJECTIVES: To ascertain childhood tuberculosis (TB) trends, human immunodeficiency virus (HIV) co-infection rates and multi-drug resistant TB (MDR-TB) prevalence rates in Zambia. METHODS: A retrospective review of Zambian annual TB notification data and National TB Programme reports for a 7 year period (2004-2011). TB trends were stratified by age and HIV status. RESULTS: The total number of children notified during this period with all forms of TB was 40 976. A total of 2670 of 40 976 (6%) were smear-positive cases. Notification rates of all forms of childhood TB show a decline in trends from 135 per 100 000 population in 2004, to 69 per 100 000 population in 2011. CONCLUSIONS: Childhood TB is an important but neglected problem in Zambia highlighted by the fact that no data exists on HIV co-infection and MDR-TB. Strengthening of the National TB Programme and diagnostics services/algorithms are required to accurately define the TB burden, HIV co-infection and MDR-TB rates in children in Zambia.
Authors: Helen E Jenkins; Arielle W Tolman; Courtney M Yuen; Jonathan B Parr; Salmaan Keshavjee; Carlos M Pérez-Vélez; Marcello Pagano; Mercedes C Becerra; Ted Cohen Journal: Lancet Date: 2014-03-24 Impact factor: 79.321
Authors: Michelle Earley; Joconiah Chirenda; Alexandra Highet; Hilda A Mujuru; Zhenhua Yang Journal: Am J Trop Med Hyg Date: 2018-07-12 Impact factor: 2.345
Authors: Anne Lia Cremers; Myrthe Manon de Laat; Nathan Kapata; Rene Gerrets; Kerstin Klipstein-Grobusch; Martin Peter Grobusch Journal: PLoS One Date: 2015-03-25 Impact factor: 3.240
Authors: Florence Mwangwa; Gabriel Chamie; Dalsone Kwarisiima; James Ayieko; Asiphas Owaraganise; Theodore D Ruel; Albert Plenty; Khai Hoan Tram; Tamara D Clark; Craig R Cohen; Elizabeth A Bukusi; Maya Petersen; Moses R Kamya; Edwin D Charlebois; Diane V Havlir; Carina Marquez Journal: J Clin Tuberc Other Mycobact Dis Date: 2017-12
Authors: Eric Wobudeya; Deus Lukoye; Irene R Lubega; Frank Mugabe; Moorine Sekadde; Philippa Musoke Journal: BMC Public Health Date: 2015-09-25 Impact factor: 3.295
Authors: Matthew Bates; Aaron Shibemba; Victor Mudenda; Charles Chimoga; John Tembo; Mwila Kabwe; Moses Chilufya; Michael Hoelscher; Markus Maeurer; Sylvester Sinyangwe; Peter Mwaba; Nathan Kapata; Alimuddin Zumla Journal: BMC Med Date: 2016-07-01 Impact factor: 8.775